Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Heathcote

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 13, 2012
A deficiency in nucleoside salvage impairs murine lymphocyte development, homeostasis, and survivalOnjee Choi, Dean A Heathcote, Ka-Kei Ho, et al.
Organic & Biomolecular Chemistry|October 4, 2014
Approaches to design non-covalent inhibitors for human granzyme B (hGrB)Mi-Sun Kim, Lauriane A Buisson, Dean A Heathcote, et al.
British Journal of Cancer|September 28, 2013
Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistanceM Kaliszczak, H Patel, S H B Kroll, et al.
Neuroimage|March 3, 2023
Investigating Intra-Individual Networks of Response Inhibition and Interference Resolution using 7T MRIS J S Isherwood, P L Bazin, S Miletić, et al.
Gene Therapy|January 14, 2005
Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-alpha and the transcriptional repressor PLZFL Buluwela, J Pike, D Mazhar, et al.
Cancer Research|July 30, 2009
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activitySimak Ali, Dean A Heathcote, Sebastian H B Kroll, et al.
Nature Medicine|June 21, 2011
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemiaRyan C Russell, Roxana I Sufan, Bing Zhou, et al.
The Journal of Clinical Investigation|August 8, 2009
HIF2alpha cooperates with RAS to promote lung tumorigenesis in miceWilliam Y Kim, Samanthi Perera, Bing Zhou, et al.
Journal of Medicinal Chemistry|November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administrationDean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 13, 2012
A deficiency in nucleoside salvage impairs murine lymphocyte development, homeostasis, and survivalOnjee Choi, Dean A Heathcote, Ka-Kei Ho, et al.
Organic & Biomolecular Chemistry|October 4, 2014
Approaches to design non-covalent inhibitors for human granzyme B (hGrB)Mi-Sun Kim, Lauriane A Buisson, Dean A Heathcote, et al.
British Journal of Cancer|September 28, 2013
Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistanceM Kaliszczak, H Patel, S H B Kroll, et al.
Neuroimage|March 3, 2023
Investigating Intra-Individual Networks of Response Inhibition and Interference Resolution using 7T MRIS J S Isherwood, P L Bazin, S Miletić, et al.
Gene Therapy|January 14, 2005
Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-alpha and the transcriptional repressor PLZFL Buluwela, J Pike, D Mazhar, et al.
Cancer Research|July 30, 2009
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activitySimak Ali, Dean A Heathcote, Sebastian H B Kroll, et al.
Nature Medicine|June 21, 2011
Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemiaRyan C Russell, Roxana I Sufan, Bing Zhou, et al.
The Journal of Clinical Investigation|August 8, 2009
HIF2alpha cooperates with RAS to promote lung tumorigenesis in miceWilliam Y Kim, Samanthi Perera, Bing Zhou, et al.
Journal of Medicinal Chemistry|November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administrationDean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.
Pageof 3